NCT06168890View on ClinicalTrials.gov

Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.

CompletedOBSERVATIONAL
Enrollment

195

Participants

Timeline

Start Date

February 4, 2014

Primary Completion Date

February 25, 2014

Study Completion Date

February 25, 2014

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PET/CT with choline in the restaging phase of prostate cancer.

PET/CT with choline in the restaging phase of prostate cancer in patients suffering from prostate cancer with biochemical recovery of the disease during hormonal therapy.

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT06168890 - Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure. | Biotech Hunter | Biotech Hunter